The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Not sure if it was a typo but interims will be released on the 18th not the 16th.
They've also said the amount they think they will make for the few weeks the product went on sale. They said about 1.5m maybe a bit more.
whatI I hope is they give a very big update on sales since the product launch and how the rollout is going in the EU and the US.
But in the past their interims have been very basic, maybe due to lack of staff and money. But with money in the bank they might produce a more detailed interim report.
Personally I feel we need to wait for the full results in April to get a good understanding on how the product is selling.
Current issues I see are, we have no idea how much money Fum are making from the deal because their contracts are very opaque. We also have Lombard, who hold a lot of shares, are still selling, as far as I'm concerned, so that is holding down the share price.
I'm hoping in Sept, when we get the interim results we'll get a better idea on monies coming in. But I suspect it won't be in April when until we get a much better idea on monies coming in.
All very frustratin for LTH's...
Great video and interesting about 20 approaches for the China market, which they've said FUM wont pay for extra trials.
As always I would have like more, like how well the plans for full EU roll out is going. News on Middle East rollout....but still a great video
Lombard (an investment company) have millions of shares to off load and that is holding down the price imo.
FUM have kept the royalties a secret because they say it's commericially senstive information as they are doing other deals.
But if you look at the RNS from 4 March 2021 they say this
Commercial Highlights:
· Co-High is responsible for all regional MED3000 development and regulatory costs, which are estimated to be up to £4 million.
· The profits of the Joint Collaboration will be shared 50:50 between Futura and Co-High.
https://www.lse.co.uk/rns/FUM/futura-announces-investment-joint-collaboration-c34mimt2fuhoi0k.html
So cannot believe that they would suddenly drop the % to single figures on other deals - imo.
But I guess we won't really know until we are start seeing sales figures etc etc. They are releasing interim figures in Sept, which they've already indcated it should be over 1.5m pounds. Which, for me, means we won't really see how it's going until April 2024 when they release final year figures
Thanks the link works...imo..........lol hahaha
Hi Bazzamn
Link doesn't work for me, as says page not found. Are you able to copy and paste the article.
Italain, I disagree with you, as I think there is/has been a seller.
Most PI don't buy/sell round figures of shares. They buy in round up monetary terms, say 1000 quid, so will get how many shares including costs. If you look at at past trading there has been a lot of units of 1000 shares being sold at a time. You'll also see that the more shares are being traded the more of these rounded up shares are sold.
Personally I don't think they are PI's. But that is my opinion. If you look before Lom got the 10 mil shares, they did actually let the market know they had reduced their holdings (and there was a lot of 1000 units sold prior to that). I will admit that Lom then had to redo the RNS because they' just got 10 mil shares. But that doesn't negate the effect they had reduced their holdings.
Hope that makes sense, as struggling with a severe hangover....d'oh.
but as I said imo
I would also say patent, esp for a company that would looking at buying FUM.
current patent is only unitl 2029 if they get the extension it will be valid until 2040.
Lombard have over 85m shares and they are reducing their holdings. They have been very supportive of FUM over the years and now they are taking profits.
All very frustrating as we've no idea how many they plan to sell and how long it will go on for.
I'm hoping an institutional buyer will take a load off them rather the shares being dripped feed into the marktet.
all imo
None, as from July it's going to sold all over the EU on Amazon and they will be expanding into more shops.
Surfi - i know that is why I'm frustrated.
I was hoping for a sustained boost at 60p, but can't hold it. Let's hope it stays above 55p as in the last year its not been able to stay over that price......
Cannot believe (actually I can), that we are still dropping. Fookin wish the seller would bugger off. Guess Lombard have a lot of shares to sell.....ggrrrr
FUM have never released the finanical deals with the companies that have deals with. But there is no cost to FUM regarding marketing/distribution etc etc. FUM only have to supply the product.
But if you look back to RNS dated 4th March 2021, they made a deal with Co-High Investment deal for China and South East Asia and the deal said that FUM would receive 50% - see below, although this deal and since fallen through.
But from this I am assuming the other commercialisation deals will be similar, imho.
I can't remember the unit price to make the product but I do remember it being very small, maybe someone else can find this information
"In addition, Futura has entered into a licensing agreement with Pride Century Ventures, a special purpose vehicle owned by Co-High Investment Management Limited ("Co-High") for the rights to exclusively develop and commercialise the Company's topical, gel-based Erectile Dysfunction ("ED") treatment MED3000, in China and South East Asia. Co-High will provide funding currently estimated to be up to £4 million for development and regulatory approval of MED3000 in the region and Futura will be entitled to 50% of regional profits from the commercialisation of MED3000 (the "Joint Collaboration")."
There is no meeting on Friday. The AGM is on Thursday, followed by the Investors Seminar (also on the 22nd) The on Monday 26th there is a Retail Investors meeting - see below
Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, is pleased to announce that it will be hosting an Investor Seminar on the 22 June 2023 in London for analysts and institutional investors. Following the Investor Seminar, an Investor Meet Company meeting will be held for Retail Investors on Monday the 26 June."
Not going to argue if that happens lol hahaha
I have a closing price of 66p on the 22 March 21. The reason I know this as I jot down in a spreadsheet the closing prices of any shares I owe - yes I know I need to get out more lol hahahaha
I wouldn't sell yet - look at the price between buy/sell it hasn't been that close for a very long time. They want your shares imo
Ybhere - fingers crossed.
If you look at the chart of the last year, we've been at this level about 5 times lets hope it pushes over the 55p sell price and hold.
I agree how did they get this wrong. We all know they just got 10 mil new shares from the warrants. So I personally didn't understand how they said they had reduced their holdings.
Let's hope they aren't in a hurry to sell the extra 10 mil as that will hold back the share price imo